ISEC Healthcare Ltd · SGX:40T
ISEC Healthcare — Q1 2016 Earnings Presentation
22 slides from ISEC Healthcare's earnings presentation, May 2016
Slide 1: Corporate Presentation – 3 months ended 31 March 2016
Corporate Presentation 3 months ended 31 March 2016 Page 0
Slide 2: Disclaimer
ISEC Healthcare Ltd. (“ISEC” or the “Company”) was listed on Catalist of the Singapore Exchange Securities Trading Limited (the “SGX-ST”) on 28 October 2014. The initial public offering of the Company was sponsored by PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”). This presentation has b
Slide 3: Table of Content
Table of Content Business Overview Industry Overview Business Strategy and Expansion Plans Use of Proceeds 3 months ended 31 March 2016 Financial Highlights Page 2
Slide 4: Business Overview
Thank You Business Overview Page 3 3
Slide 5: Business Overview
Business Overview • ISEC is a comprehensive medical eye care service provider, with ambulatory surgical centres in Malaysia (Kuala Lumpur, Penang & Malacca) and provides specialist medical ophthalmology services to Lee Hung Ming Eye Centre in Gleneagles Hospital (Singapore) • We specialise in the fi
Slide 6: Competitive Strengths of the Group
Business Overview Competitive Strengths of the Group 1 Highly qualified and experienced specialist doctors 6 Business model aligns the 2 interests of our High quality and specialist doctors with comprehensive range of our Group and eye care services Shareholders 5 Ability to replicate our 3 Well pos
Slide 7: Industry Overview
Thank You Industry Overview Page 6 6
Slide 8: Key Drivers for Private Ophthalmology
Industry Overview Key Drivers for Private Ophthalmology AGEING POPULATION with large elderly 25.9% of population in Malaysia above 40 years old in 2013, expected to patient group suffering from cataract, grow at CAGR of 1.7% from 2013 to 2018 glaucoma, AMD, dry eyes or vitreoretinal diseases as thes
Slide 9: Key Drivers for Private Ophthalmology (cont'd)
Industry Overview Key Drivers for Private Ophthalmology (cont’d) Medical tourism based healthcare expenditure forecast to grow at 26.7% GOVERNMENT SUPPORT IN PROMOTING CAGR from 2009 to 2018 in Malaysia MEDICAL TOURISM leading to generation of additional demand for medical services Medical tourism b
Slide 10: Business Strategy and Expansion Plans
Thank You Business Strategy And Expansion Plans Page 9 9
Slide 11: Our Business Strategies
Our Business Strategies To reach more patients in locations where we currently Growing the ISEC operate, as well as new locations such as major cities or Brand and locations in Peninsular Malaysia, East Malaysia and Singapore Expanding into To expand via setting up of subsidiaries, JV, expand existi
Slide 12: Expansion Plans
Expansion Plans Business expansion in the Asia pacific region (including Malaysia Malaysia & and Singapore) Singapore Target Countries Page 11
Slide 13: Use of Proceeds
Thank You Use of Proceeds Page 12 12
Slide 14: Use of Proceeds
Use of Proceeds As at 12 May 2016 Amount allocated pursuant to reallocation of Use of proceeds Amount unutilized listing Amount allocated expenses utilised Balance S$’000 S$’000 S$’000 S$’000 Business expansion in Asia Pacific region (including Malaysia and 13,800 14,100 (5,326) (N1) 8,774 Singapore
Slide 15: 3 Months Financial Highlights
Thank You 3 Months Financial Highlights for the period ended 31 March 2016 Page 14 14
Slide 16: Revenue
Revenue SGD’mil Q12016 vs Q12015 Group revenue was higher. The increase was attributable to higher revenue contribution from Malaysia operations. SSEC which was acquired on 8 December 2015 contributed S$0.8 million to the Group’s revenue in 1Q2016. Revenue from Singapore operations had decreased by
Slide 17: Revenue – Malaysia
Revenue – Malaysia RM’mil SGD’mil 31.3% 16.3% Revenue from Malaysia operations in Ringgit Malaysia (“RM”) increased from RM13.1 million in Q12015 to RM17.2 million in Q12016, up 31.3% mainly due to increased number of patients visits in ISEC KL and ISEC Penang and the inclusion of results from SSEC
Slide 18: Revenue – By location/clinic
Revenue – By location/clinic SGD’mil Notes: (1) On 8 Dec 2015, the Group completed the acquisition of Southern Specialist Eye Centre Sdn. Bhd. (“SSEC”) (2) ISEC Eye – revenue from Lee Hung Ming Eye Centre (3) ISEC Sg – revenue from ISEC Singapore (which ceased operations in October 2015) Page 17
Slide 19: EBITDA and Profit After Tax (PAT)
Earnings Before Interest Tax Depreciation and Amortisation (EBITDA) and Profit After Tax (PAT) SGD’000 EBITDA was S$2.3 million in Q12016 as compared to S$1.5 million in Q12015 mainly due to higher revenue contribution from SSEC and lower cost of sales, selling and distribution expenses and administ
Slide 20: Cash Position
Cash Position Total cash and cash equivalents Unutilized IPO proceeds Cash balances SGD’mil Total cash and cash equivalents as at 31 March 2016 was S$26.3 million. No debts. Cash balances (exclude unutilized IPO proceeds) increased from S$16.1 million as at 31 Dec 2015 to S$17.5 million as at 31 Mar
Slide 21: Statement of Financial Position
Statement of Financial Position S$’000 31 March 31 December 2016 2015 Key Assets Plant and equipment 3,619 3,639 Intangible assets^ 25,603 25,162 Trade and other receivables 1,648 1,905 Cash and cash equivalents 26,340 24,924 Key Liabilities Trade and other payables 2,556 3,410 Equity Shareholders e
Slide 22: Thank You
Thank You Thank You Page 21 21